SCHEMBL23296403

SCHEMBL23296403

Cc1ccc2c3ccc(C)cc3n(-c3cc(-c4nc(-c5ccccc5)nc(-c5ccccc5)n4)cc(-n4c5cc(C)ccc5c5ccc(C)cc54)c3C#N)c2c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA1 P30542 8/20 0.39
ADORA2A P29274 7/20 0.39
NPSR1 Q6W5P4 2/20 0.39
KDM4E B2RXH2 2/20 0.39
HPGD P15428 2/20 0.39
PPARG P37231 1/20 0.39
NCOA2 Q15596 1/20 0.39
NCOA1 Q15788 1/20 0.39
NCOA3 Q9Y6Q9 1/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
ADORA3 P0DMS8 3/20 0.38
HSD17B10 Q99714 2/20 0.38
ADORA2B P29275 1/20 0.38
NR1I2 O75469 1/20 0.38
EGFR P00533 1/20 0.38
ADRA2A P08913 1/20 0.38
TBXA2R P21731 1/20 0.38
PTGS2 P35354 1/20 0.38
OPRD1 P41143 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31273449 0.93 ADORA1 (0.45) ADORA1ADORA2ANPSR1KDM4EHPGD
SCHEMBL31272885 0.92 ADORA1 (0.44) ADORA1ADORA2ANPSR1KDM4EHPGD
SCHEMBL19942701 0.90 ADORA1 (0.39) ADORA1ADORA2ANPSR1KDM4EHPGD
SCHEMBL19942704 0.89 PDE9A (0.38) ADORA1ADORA2ANPSR1KDM4EHPGD
SCHEMBL22563686 0.87 NPSR1 (0.34) NPSR1KDM4EHPGDPPARGNCOA1
SCHEMBL19942705 0.87 NPSR1 (0.34) ADORA1ADORA2ANPSR1KDM4EHPGD
SCHEMBL22563389 0.87 ABCG2 (0.41) ADORA1ADORA2ANPSR1KDM4EHPGD
SCHEMBL19942791 0.87 L3MBTL1 (0.44) ADORA1ADORA2ANPSR1KDM4EHPGD
SCHEMBL22563684 0.87 PDE9A (0.35) ADORA1ADORA2ANPSR1KDM4EHPGD
SCHEMBL19942707 0.87 PDE9A (0.35) ADORA1ADORA2ANPSR1KDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4498784-A2 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES Kyulux, Inc. (JP) 2025-01-29 EP disclosed
EP-3775100-B1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES KYULUX INC (JP) 2025-01-22 EP disclosed
US-20210135119-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES KYULUX, INC. (JP) 2021-05-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210135119-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES CRY2, SLCO1B3, NDUFV3 ADORA1 3690/4885ADORA2A 1368/4885NPSR1 2462/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.